Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer

SIMPLE SUMMARY: HER2+ and triple negative breast cancers are widely known for their aggressiveness, frequent resistance to treatment and poor prognosis. Neoadjuvant management has provided promising results for both subtypes, but there is still a subset of patients with no or low response. Consequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pons, Laura, Hernández, Laura, Urbizu, Aintzane, Osorio, Paula, Rodríguez-Martínez, Paula, Castella, Eva, Muñoz, Ana, Sanz, Carolina, Arnaldo, Laura, Felip, Eudald, Quiroga, Vanesa, Tapia, Gustavo, Margelí, Mireia, Fernandez, Pedro Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296027/
https://www.ncbi.nlm.nih.gov/pubmed/37370679
http://dx.doi.org/10.3390/cancers15123068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296027/
https://www.ncbi.nlm.nih.gov/pubmed/37370679
http://dx.doi.org/10.3390/cancers15123068

Ejemplares similares